Publications by authors named "David Looper"

Claim this Profile
E
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Kevin Freeman-Cook, Robert L Hoffman, Nichol Miller, Jonathan Almaden, John Chionis, David Looper

Cancer Cell· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
Helen Cho, Shawn C Black, David Looper, Manli Shi, Dawn Kelly-Sullivan

Am J Physiol Endocrinol Metab· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPS-induced biomarkers in mice: a potential model for identifying insulin sensitizers.
Celia P Briscoe, David Looper, Phong Tran, Jocelyn Herrera, Scott R McDonnell

Biochem Biophys Res Commun· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant adenovirus-p21 attenuates proliferative responses associated with excessive scarring.
Danling Gu, Isabella Atencio, David W Kang, L David Looper, C M I Ahmed

Wound Repair Regen· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor growth inhibition by interferon-alpha using PEGylated protein or adenovirus gene transfer with constitutive or regulated expression.
G William Demers, Duane E Johnson, Todd Machemer, L David Looper, Amy Batinica

Mol Ther· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis